We only have this paper's title and publication details.
Read it at the sourceAnswers are grounded in this paper and cite their sources.
Oral vorinostat was effective in treatment refractory MF/SS with an acceptable safety profile.
No takes yet. Share an insight, caveat, or question.
Olsen et al. (2007) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: